Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity - PubMed (original) (raw)
. 2005 Jun;90(6):3498-504.
doi: 10.1210/jc.2004-2240. Epub 2005 Mar 29.
Uberto Pagotto, Rita Manini, Ester Vanni, Amalia Gastaldelli, Rosaria de Iasio, Elena Gentilcore, Stefania Natale, Maurizio Cassader, Mario Rizzetto, Renato Pasquali, Giulio Marchesini
Affiliations
- PMID: 15797948
- DOI: 10.1210/jc.2004-2240
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
Elisabetta Bugianesi et al. J Clin Endocrinol Metab. 2005 Jun.
Abstract
Plasma levels of adiponectin are decreased in patients with nonalcoholic fatty liver disease (NAFLD), but the relationship among plasma adiponectin, insulin sensitivity, and histological features is unclear. In 174 NAFLD patients and 42 controls, we examined plasma adiponectin concentrations in relation to 1) lipid profile, indices of insulin resistance, and features of the metabolic syndrome (n = 174); 2) hepatic insulin resistance (clamp technique with tracer infusion) (10 patients); and 3) histological features at liver biopsy (n = 116). When the data from all subjects were combined, plasma adiponectin levels were positively associated with increased age, female gender, and plasma high-density lipoprotein levels, and negatively associated with waist circumference, body mass index, triglycerides, indices of insulin resistance, and aminotransferase levels, and also predicted the presence of the metabolic syndrome. In step-wise regression, increased age, female gender, waist circumference, triglyceride levels, and homeostasis model assessment independently associated with adiponectin (adjusted R(2), 0.329). In NAFLD, adiponectin was only associated with increased age, female gender, and triglycerides (adjusted R(2), 0.245). When the measured histological parameters were included in the model, plasma adiponectin levels were also inversely proportional to the percentage of hepatic fat content (adjusted R(2), 0.221), whereas necroinflammation and fibrosis did not fit in the model. Adiponectin was negatively correlated with insulin-suppressed endogenous glucose production during the clamp (P = 0.011). The results demonstrate that decreased levels of circulating adiponectin in NAFLD are related to hepatic insulin sensitivity and to the amount of hepatic fat content. Hypoadiponectinemia in NAFLD is part of a metabolic disturbance characterized by ectopic fat accumulation in the central compartment.
Similar articles
- Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G. Targher G, et al. Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83. doi: 10.1111/j.1365-2265.2006.02527.x. Clin Endocrinol (Oxf). 2006. PMID: 16712671 - Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J. Savvidou S, et al. J Clin Gastroenterol. 2009 Sep;43(8):765-72. doi: 10.1097/MCG.0b013e31819e9048. J Clin Gastroenterol. 2009. PMID: 19525862 - Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
Ercin CN, Dogru T, Tapan S, Kara M, Haymana C, Karadurmus N, Karslioglu Y, Acikel C. Ercin CN, et al. Metabolism. 2010 Jul;59(7):977-81. doi: 10.1016/j.metabol.2009.10.019. Epub 2009 Dec 31. Metabolism. 2010. PMID: 20045153 - The fatty liver and insulin resistance.
Yki-Järvinen H, Westerbacka J. Yki-Järvinen H, et al. Curr Mol Med. 2005 May;5(3):287-95. doi: 10.2174/1566524053766031. Curr Mol Med. 2005. PMID: 15892648 Review. - The role of the novel adipocyte-derived hormone adiponectin in human disease.
Díez JJ, Iglesias P. Díez JJ, et al. Eur J Endocrinol. 2003 Mar;148(3):293-300. doi: 10.1530/eje.0.1480293. Eur J Endocrinol. 2003. PMID: 12611609 Review.
Cited by
- Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ, Wang PW, Hu TH. Hsieh CJ, et al. PLoS One. 2015 Jun 4;10(6):e0127521. doi: 10.1371/journal.pone.0127521. eCollection 2015. PLoS One. 2015. PMID: 26042596 Free PMC article. - Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G, Bugianesi E, Bouserhal T, Marini F, Ridolfi F, Tarsetti F, Ancarani F, Petrelli E, Peruzzi E, Lo Cascio M, Rizzetto M, Marchesini G, Benedetti A. Svegliati-Baroni G, et al. Gut. 2007 Sep;56(9):1296-301. doi: 10.1136/gut.2006.107946. Epub 2007 Mar 28. Gut. 2007. PMID: 17392334 Free PMC article. - Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.
Nazal L, Riquelme A, Solís N, Pizarro M, Escalona A, Burotto M, Méndez JI, Saint-Jean C, Concha MJ, Giovanni S, Awruch D, Morales A, Baudrand R, Carrasco G, Domínguez MA, Padilla O, Espinoza M, Miquel JF, Nervi F, Arrese M. Nazal L, et al. Obes Surg. 2010 Oct;20(10):1400-7. doi: 10.1007/s11695-009-0051-0. Epub 2010 Jan 12. Obes Surg. 2010. PMID: 20066503 - Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
Kotronen A, Yki-Järvinen H, Männistö S, Saarikoski L, Korpi-Hyövälti E, Oksa H, Saltevo J, Saaristo T, Sundvall J, Tuomilehto J, Peltonen M. Kotronen A, et al. BMC Public Health. 2010 May 10;10:237. doi: 10.1186/1471-2458-10-237. BMC Public Health. 2010. PMID: 20459722 Free PMC article. - Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.
Lakhani HV, Sharma D, Dodrill MW, Nawab A, Sharma N, Cottrill CL, Shapiro JI, Sodhi K. Lakhani HV, et al. Int J Med Sci. 2018 Oct 20;15(14):1591-1599. doi: 10.7150/ijms.27953. eCollection 2018. Int J Med Sci. 2018. PMID: 30588181 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources